Search - tctmd.com

Displaying 61 - 80 of 209

Sort: Relevancy | Date

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

March 31, 2022

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

COVID-19: TCTMD’s Dispatch for March Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 2

March 07, 2022

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 2

February 07, 2022

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

News Daily News

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Yael L. Maxwell

January 24, 2022

‘Home Time’ Validated as TAVI Outcomes Performance Metric

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

January 11, 2022

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

News Daily News

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

December 28, 2021

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

November 30, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

Good TAVI Outcomes in Young Patients, but Population Is Unique

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

October 20, 2021

ACC Survey Reveals Racial/Ethnic Gaps but Also Job Satisfaction

News Daily News

ACC Survey Reveals Racial/Ethnic Gaps but Also Job Satisfaction

October 18, 2021

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Compensation in 2020 Survived COVID-19, CV Professionals Say

News Daily News

Compensation in 2020 Survived COVID-19, CV Professionals Say

September 10, 2021

Female Trainees Still Dissuaded by Electrophysiology ‘Old Boys’ Club,’ Says ACC Survey

News Daily News

Female Trainees Still Dissuaded by Electrophysiology ‘Old Boys’ Club,’ Says ACC Survey

August 23, 2021

PAD Continues to Elude Clinicians, Despite Gains: AHA

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

August 05, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.